Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Neurotrack completes venture financing

    Neurotrack Technologies Inc., Palo Alto, Calif. Business: Diagnostic Date completed: 2016-01-27 Type: Venture financing Raised: $6.5 million Investors: Khosla Ventures; Social Capital; Founders Fund; AME Cloud Ventures;…

    Published on 2/1/2016
  • Novavax completes private placement of senior convertible notes

    Novavax Inc. (NASDAQ:NVAX), Gaithersburg, Md. Business: Infectious Date completed: 2016-01-25 Type: Private placement of senior convertible notes Raised: $300 million Shares outstanding prior: 269.9 million Investor: …

    Published on 2/1/2016
  • Starpharma completes private placement

    Starpharma Holdings Ltd. (ASX:SPL; OTCQX:SPHRY), Melbourne, Australia Business: Infectious Date completed: 2016-01-20 Type: Private placement Raised: A$1.9 million ($1.3 million) Shares: 2.6 million Price: A$0.73 Shares…

    Published on 2/1/2016
  • Tarveda Therapeutics completes venture financing

    Tarveda Therapeutics Inc., Watertown, Mass. Business: Cancer Date completed: 2016-01-27 Type: Venture financing Raised: $38 million Investors: Novo A/S; New Enterprise Associates; Flagship Ventures; NanoDimension; …

    Published on 2/1/2016
  • Apollo Therapeutics Fund financial update

    Apollo Therapeutics Fund, not disclosed Business: Finance Date announced: 2016-01-25 Note: Three pharmas and the tech transfer offices of three U.K. universities launched the L40 million ($57 million) Apollo …

    Published on 2/1/2016
  • Kane proposes private placement of units

    Kane Biotech Inc. (TSX-V:KNE), Winnipeg, Manitoba Business: Drug delivery, Dermatology Date announced: 2016-01-27 Type: Private placement of units To be raised: C$4 million ($2.8 million) Units: 66.7 million Price: C$0.…

    Published on 2/1/2016
  • Spectral Medical proposes follow-on

    Spectral Medical Inc. (TSX:EDT; OTCQX:EDTXF), Toronto, Ontario Business: Diagnostic Date announced: 2016-01-28 Type: Follow-on To be raised: Up to C$10 million ($7 million) Shares: 14.3 million Price: C$0.70 Underwriter…

    Published on 2/1/2016
  • BeiGene amends IPO

    BeiGene Ltd., Beijing, China Business: Cancer, Autoimmune Date announced: 2016-01-19 Type: IPO To be raised: Up to $132 million Shares: 5.5 million Price: $22-$24 Underwriters: Goldman Sachs; Morgan Stanley; Cowen; …

    Published on 1/25/2016
  • Merus amends IPO

    Merus B.V., Utrecht, the Netherlands Business: Antibodies, Cancer Date announced: 2016-01-21 Type: IPO To be raised: TBD Shares: TBD Price: TBD Underwriters: Citigroup; Jefferies; Guggenheim Securities; Wedbush Note: …

    Published on 1/25/2016
  • PLx Pharma amends IPO

    PLx Pharma Inc., Houston, Texas Business: Autoimmune, Neurology Date announced: 2016-01-15 Type: IPO To be raised: Up to $72.2 million Shares: 3.8 million Price: $17-$19 Underwriters: Raymond James; Maxim Group; Janney …

    Published on 1/25/2016
  • Spring Bank amends IPO

    Spring Bank Pharmaceuticals Inc., Milford, Mass. Business: Infectious, Pulmonary Date announced: 2016-01-15 Type: IPO To be raised: TBD Shares: TBD Price: TBD Underwriters: William Blair; Wedbush; BTIG Note: Spring Bank…

    Published on 1/25/2016
  • 20/20 GeneSystems completes venture financing

    20/20 GeneSystems Inc., Rockville, Md. Business: Diagnostic Date completed: 2016-01-14 Type: Venture financing Raised: $4.5 million Investors: Ping An Ventures; and other undisclosed investors

    Published on 1/25/2016
  • Agile Therapeutics completes follow-on

    Agile Therapeutics Inc. (NASDAQ:AGRX), Princeton, N.J. Business: Genitourinary, Endocrine/Metabolic Date completed: 2016-01-22 Type: Follow-on Raised: $35 million Shares: 5.5 million Price: $6.35 Shares after offering: …

    Published on 1/25/2016
  • arGEN-X completes private placement

    arGEN-X N.V. (Euronext:ARGX), Breda, the Netherlands Business: Antibodies, Cancer, Autoimmune Date completed: 2016-01-22 Type: Private placement Raised: EUR16 million ($17.4 million) Shares: 1.5 million Price: EUR10.79 …

    Published on 1/25/2016
  • Biodesy completes venture financing

    Biodesy Inc., Burlingame, Calif. Business: Supply/Service, Computational chemistry/biology, Proteomics Date completed: 2016-01-21 Type: Venture financing Raised: $10 million Investors: 5AM Ventures; Pfizer Venture …

    Published on 1/25/2016
  • bioTheranostics completes venture financing

    bioTheranostics Inc., San Diego, Calif. Business: Diagnostic Date completed: 2016-01-21 Type: Venture financing Raised: $32 million Investors: MVM Life Science Partners; Canepa Advanced Healthcare; HealthQuest Capital

    Published on 1/25/2016
  • CASI Pharmaceuticals completes private placement of common stock and warrants

    CASI Pharmaceuticals Inc. (NASDAQ:CASI), Rockville, Md. Business: Cancer, Autoimmune Date completed: 2016-01-19 Type: Private placement of common stock and warrants Raised: $10.3 million Shares: 8.4 million Price: $1.19…

    Published on 1/25/2016
  • Centauri Therapeutics completes venture financing

    Centauri Therapeutics Ltd., Kent, U.K. Business: Infectious Date completed: 2016-01-18 Type: Venture financing Raised: Not disclosed Investors: Animatrix Capital; private investors Note: Centauri raised an undisclosed …

    Published on 1/25/2016
  • HiberGene Diagnostics completes venture financing

    HiberGene Diagnostics Ltd., Dublin, Ireland Business: Diagnostic Date completed: 2016-01-19 Type: Venture financing Raised: EUR1.5 million ($1.6 million) Investor: Private investors Note: HiberGene raised EUR1.5 million…

    Published on 1/25/2016
  • MabVax Therapeutics completes debt financing

    MabVax Therapeutics Holdings Inc. (OTCQB:MBVX), San Diego, Calif. Business: Cancer Date completed: 2016-01-19 Type: Debt financing Raised: $5 million Investor: Oxford Finance Note: MabVax drew down $5 million from a new…

    Published on 1/25/2016
  • Starpharma completes private placement

    Starpharma Holdings Ltd. (ASX:SPL; OTCQX:SPHRY), Melbourne, Australia Business: Infectious Date completed: 2016-01-20 Type: Private placement Raised: A$1.9 million ($1.3 million) Shares: 2.6 million Price: A$0.73 Shares…

    Published on 1/25/2016
  • Theracos completes venture financing

    Theracos Inc., Marlborough, Mass. Business: Endocrine/Metabolic Date completed: 2016-01-05 Type: Venture financing Raised: $25 million Investor: Not disclosed Note: Theracos raised $25 million in an undisclosed …

    Published on 1/25/2016
  • Twist Bioscience completes venture financing

    Twist Bioscience Corp., San Francisco, Calif. Business: Biomanufacturing, Supply/Service Date completed: 2016-01-19 Type: Venture financing Raised: $61 million Investors: Arch Overage Fund; Merieux Developpement; …

    Published on 1/25/2016
  • vasopharm completes venture financing

    vasopharm GmbH, Wuerzburg, Germany Business: Cardiovascular, Inflammation, Neurology Date completed: 2016-01-21 Type: Venture financing Raised: EUR20 million ($21.8 million) Investors: Entrepreneurs Fund; Heidelberg …

    Published on 1/25/2016
  • Abingworth Management financial update

    Abingworth Management, London, U.K. Business: Finance Date announced: 2016-01-21 Note: Abingworth closed a $105 million fund dedicated to risk-sharing investments in late-stage clinical therapeutic programs from biotech…

    Published on 1/25/2016

< Previous   1  2  3  4  5  6  7  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993